Clinical Trials Browser

OTHER × Neoplasms × Floxuridine × Clear all

NCT00587067 2023-04-04

A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy

Phase 2 Completed

34 enrolled 12 charts

Gastrointestinal

Liver Neoplasms, Neoplasms